FLT3 and cancer: To ask whether FLT3-ITD cells are dependent of CDC25A activity for their proliferation, we first used IRC-083864, a potent pharmacological inhibitor of CDC25 (A, B and C) previously characterized in vitro and in vivo in different cancer models [23].